Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
A coma is a deep condition of unconsciousness that prevents awakening and limits stimulus response. Due to its complicated etiology, different causes, and changing severity, coma diagnosis and treatment are difficult, affecting market dynamics.
Coma's cause must be determined by reviewing the patient's medical history, physical exam, and diagnostic testing such MRI, EEG, and laboratory tests. However, the large variety of probable causes and the urgency of identifying and treating reversible variables make accurate and prompt diagnosis difficult, altering market dynamics by influencing treatment options and results.
Coma treatment depends on the cause and severity. To stabilize the patient, airway management, oxygen treatment, and intravenous fluids may be needed immediately. Optimizing results requires targeted therapies such metabolic problem drugs or cerebral hemorrhage surgery. The treatment landscape affects market dynamics by encouraging intervention uptake and novel treatment modalities.
Neuroprotective, neuromodulation, and regenerative medicine treatments for coma are being studied. New treatments like hypothermia and neurostimulation may help coma sufferers. These novel therapies may change market dynamics by offering alternatives and meeting medical demands.
The economic burden of coma comprises diagnosis, treatment, and long-term care expenditures, as well as indirect costs including productivity loss and caregiver strain. Healthcare expense, reimbursement regulations, and treatment availability are affected by economic considerations.
The FDA in the US and the EMA in Europe approve and commercialize coma diagnostic and treatment equipment and drugs. Market access depends on regulatory compliance, which affects market dynamics. These treatments are regulated to guarantee safety and effectiveness, affecting market penetration and competitiveness.
The coma diagnostic and treatment industry is highly competitive among medical device, pharmaceutical, and healthcare providers. Product innovation, price, distribution methods, and strategic partnerships affect market dynamics. To compete, companies provide enhanced features, dependability, and cost-effectiveness.
Coma therapy procedures are influenced by patient preferences like treatment adherence and quality of life. Patients and their family prioritize functional results, neurological rehabilitation, and long-term quality of life while selecting treatments. Through treatment options and healthcare delivery methods, patient-centered care and collaborative decision-making affect market dynamics.
Regional differences in healthcare infrastructure, specialist care, and coma diagnosis and treatment affect market dynamics. Emerging countries may struggle to meet coma patients' demands owing to insufficient resources and healthcare facilities. However, awareness and technology boost worldwide market development and expansion.
Advances in neuroimaging, EEG monitoring, and neuromodulation treatments in coma diagnosis and treatment change market dynamics. These advances address unmet requirements and increase demand for novel coma management solutions by improving diagnostic accuracy, therapeutic effectiveness, and patient outcomes.
Market demand, technical advances, and regulatory incentives drive coma diagnostic and treatment research. Government, private, and charity funding stimulates economic market innovation and dynamism.
Patient advocacy groups and non-profits raise awareness about coma, assist patients and families, and advocate for research funding and specialized treatment. Awareness promotes early diagnosis and treatment, affecting market dynamics.
The coma diagnosis and treatment market is predicted to expand and innovate because to technological advances, patient-centered care, and customized medication. The future of the coma market depends on stakeholder collaboration, research and development, and governmental actions to provide access to specialist treatment.
Coma Diagnosis and Treatment Market Highlights:
Coma Diagnosis and Treatment Market Scenario
The coma diagnosis & treatment market is expected to reach USD 5,711.78 Million by 2030 at 7.5% CAGR during the forecast period 2022-2030.Coma refers to a state of unconsciousness in which a patient remains unresponsive to anything around them for a prolonged period of time. Depending on the severity of the coma, patient may require life-saving resuscitative measures and once the patient is medically stable, treatments can be used to treat original problem that is causing the coma.
There are various causes of coma such as traumatic brain injuries and are often caused by accidents or acts of violence. Strokes occur due to reduced or interrupted blood supply to the brain which is caused by blocked arteries or a burst blood vessel resulting in a coma. The other main cause of coma is tumors in the brain or brainstem. In some cases overdosing on drugs or alcohol can result in coma. Moreover, people with diabetes, blood sugar levels that become too high (hyperglycemia) or too low (hypoglycemia) causes coma. People who have been rescued from drowning or those who have been resuscitated after a heart attack may not awaken due to lack of oxygen to the brain. Furthermore infections such as encephalitis and meningitis cause swelling or inflammation of the brain, spinal cord or the tissues that surround the brain in severe cases of these infections can result in coma. Moreover, in some cases exposure to toxins, such as carbon monoxide or lead, can cause brain damage and coma.
Increasing prevalence of neurological disorders, increasing investment by biotechnology and pharmaceutical industries in R&D, and rising need for the better treatment methods drive the growth of the market. Moreover, favorable reimbursement policies, increased application and significant investments in the development of new technologies for the treatment of diseases will fuel the market growth during the forecast period
Furthermore, globalization in healthcare has increased the market growth. Established market players in the developed countries leads the globalization by pushing new products and services into the developing countries and emerging economies.Â
According to the World Health Organization estimates, neurological disorders are responsible for 4.5%-11% of all illnesses including low or high income economies. This is far higher as compared to the number of respiratory ailments, gastrointestinal disorders, or cancers, and the burden is expected to increase further over the coming years.
However, limited availability of facilities and higher treatment cost may hamper the coma diagnosis & treatment market growth during the forecast period.
Intended Audience
- Pharmaceutical and Biotechnological Companies
- Research and Development (R&D) Companies
- Ambulatory Care Centers
- Academic Institutes and Universities
- Market Research and Consulting Service Providers
- Potential InvestorsÂ
Figure: Coma Diagnosis & Treatment Market, By Region Market Share, 2016 (%) 
Sources: Annual reports, Press release, White paper, Company presentation
Segmentations
The coma diagnosis & treatment market is segmented on the basis of types, diagnosis, treatment, and end user.
On the basis of the type, it is segmented into toxic- metabolic encephalopathy, anoxic brain injury, persistent vegetative state, locked-in syndrome, and brain death. Â
On the basis of diagnosis it is segmented into physical examination, blood test, brain scans, and others. Brain scan is further segmented into computerized tomography (CT) scan, magnetic resonance imaging (MRI) and electroencephalography (EEG).
On the basis of treatment it is segmented into medical treatment, and others.
On the basis of the end user, it is segmented into hospitals & clinics, research laboratories and others.
Regional Analysis
The Americas dominate the coma diagnosis & treatment market owing to well-developed technology, increasing patient population for brain disorder, high health care spending, and increasing government support for research & development. Furthermore, increased R&D activities and the concentration of major companies have fuelled the growth of the coma diagnosis & treatment market in this region.
Europe holds the second position in the coma diagnosis & treatment market owing to the government support for research & development and availability of funds for research. This is expected to continue to drive the European market over the forecasted period. For instance, developed economies such countries such as Germany and France are increasing investment in the healthcare domain and are focusing more on hospital infrastructure.
Asia Pacific is the fastest growing coma diagnosis & treatment market owing to the presence of rapidly developing healthcare technology, increasing stressful life, and high healthcare expenditure. Moreover, increasing patient population in countries like India and South Korea are likely to emerge as the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare is projected to lead the use of advanced equipment, which, in turn, may increase the coma diagnosis & treatment market growth in this region. Â
On the other hand, the Middle East & Africa holds the least share of the coma diagnosis & treatment market owing to less availability of funds, limited medical facilities, and deprived political conditions in Africa.
Key Players
Some of key the players in the market are Fujifilm Holdings (Japan), GE Healthcare (U.S.), Siemens Healthcare(U.S.), Philips Healthcare (U.S.), Shimadzu Corporation (Japan), Toshiba Medical Systems Corporation (Japan),  Carestream Health (U.S.), Nihon Kohden Corporation (Japan), Electrical Geodesics Inc. (U.S.), Masimo Corporation (U.S.), Hologic (U.S.), Esaote (Italy), and others.Â
Research Methodology 
Sources: Annual reports, Press release, White paper, and Company presentation
Â
Â
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
